263 related articles for article (PubMed ID: 38239352)
1. MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.
Meyer M; Parpoulas C; Barthélémy T; Becker JP; Charoentong P; Lyu Y; Börsig S; Bulbuc N; Tessmer C; Weinacht L; Ibberson D; Schmidt P; Pipkorn R; Eichmüller SB; Steinberger P; Lindner K; Poschke I; Platten M; Fröhling S; Riemer AB; Hassel JC; Roberti MP; Jäger D; Zörnig I; Momburg F
Front Immunol; 2023; 14():1294565. PubMed ID: 38239352
[TBL] [Abstract][Full Text] [Related]
2. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies.
Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM
J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the immunological effects of 5-azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.
Frøsig TM
Dan Med J; 2015 Aug; 62(8):B5144. PubMed ID: 26239596
[TBL] [Abstract][Full Text] [Related]
4. Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypes.
Sun Y; Young MC; Woodward CH; Danon JN; Truong HV; Gupta S; Winters TJ; Font-Burgada J; Burslem GM; Sgourakis NG
Proc Natl Acad Sci U S A; 2023 Jun; 120(25):e2304055120. PubMed ID: 37310998
[TBL] [Abstract][Full Text] [Related]
5. Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells.
Saini SK; Tamhane T; Anjanappa R; Saikia A; Ramskov S; Donia M; Svane IM; Jakobsen SN; Garcia-Alai M; Zacharias M; Meijers R; Springer S; Hadrup SR
Sci Immunol; 2019 Jul; 4(37):. PubMed ID: 31324690
[TBL] [Abstract][Full Text] [Related]
6. Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypes.
Sun Y; Young MC; Woodward CH; Danon JN; Truong H; Gupta S; Winters TJ; Burslem G; Sgourakis NG
bioRxiv; 2023 Mar; ():. PubMed ID: 36993702
[TBL] [Abstract][Full Text] [Related]
7. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
[TBL] [Abstract][Full Text] [Related]
8. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
[TBL] [Abstract][Full Text] [Related]
9. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
10. Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations.
Shen M; Chen S; Han X; Hao Y; Wang J; Li L; Chen T; Wang B; Zou L; Zhang T; Zhang W; Han X; Wang W; Yu H; Li K; Liu S; Jin A
Cancer Immunol Immunother; 2024 Jun; 73(8):150. PubMed ID: 38832948
[TBL] [Abstract][Full Text] [Related]
11. High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules.
Moritz A; Anjanappa R; Wagner C; Bunk S; Hofmann M; Pszolla G; Saikia A; Garcia-Alai M; Meijers R; Rammensee HG; Springer S; Maurer D
Sci Immunol; 2019 Jul; 4(37):. PubMed ID: 31324691
[TBL] [Abstract][Full Text] [Related]
12. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
[TBL] [Abstract][Full Text] [Related]
13. HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responses.
van Buuren MM; Dijkgraaf FE; Linnemann C; Toebes M; Chang CX; Mok JY; Nguyen M; van Esch WJ; Kvistborg P; Grotenbreg GM; Schumacher TN
J Immunol; 2014 Jan; 192(2):641-8. PubMed ID: 24342804
[TBL] [Abstract][Full Text] [Related]
14.
Schmidt J; Guillaume P; Dojcinovic D; Karbach J; Coukos G; Luescher I
J Biol Chem; 2017 Jul; 292(28):11840-11849. PubMed ID: 28536262
[TBL] [Abstract][Full Text] [Related]
15. CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
Baumgaertner P; Schmidt J; Costa-Nunes CM; Bordry N; Guillaume P; Luescher I; Speiser DE; Rufer N; Hebeisen M
Front Immunol; 2022; 13():973986. PubMed ID: 36032094
[TBL] [Abstract][Full Text] [Related]
16. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes.
Lev A; Novak H; Segal D; Reiter Y
J Immunol; 2002 Sep; 169(6):2988-96. PubMed ID: 12218113
[TBL] [Abstract][Full Text] [Related]
18. A mutant human beta2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptors.
Walter JB; Garboczi DN; Fan QR; Zhou X; Walker BD; Eisen HN
J Immunol Methods; 1998 May; 214(1-2):41-50. PubMed ID: 9692857
[TBL] [Abstract][Full Text] [Related]
19. Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics.
Ade CM; Sporn MJ; Das S; Yu Z; Hanada KI; Qi YA; Maity T; Zhang X; Guha U; Andresson T; Yang JC
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37758652
[TBL] [Abstract][Full Text] [Related]
20. Evolution of MHC-based technologies used for detection of antigen-responsive T cells.
Bentzen AK; Hadrup SR
Cancer Immunol Immunother; 2017 May; 66(5):657-666. PubMed ID: 28314956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
